Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...
Health care technology company Abbott has recalled certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring systems because the sensors are displaying incorrect glucose ...
Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring (CGM) systems in the US after determining that a number of them may be ...
Abbott Laboratories has initiated a voluntary recall of a small number of FreeStyle Libre 3 sensors within three lots distributed throughout the US. Designed to be what the company says is the world’s ...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the t:slim X2™ insulin pump with Control-IQ+ TM automated insulin delivery ...
Abbott’s FreeStyle Libre 3 approved by FDA The FreeStyle Libre 3 system, the smallest and thinnest CGM sensor in the world, has the strongest Bluetooth integration with a range of up to 33 ft., the ...
The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...
For 25 years, I've had Type 1 diabetes. Like the tens of millions of Americans with diabetes, one of the most important things I have to do to stay healthy is make sure my blood sugar is in normal ...
Credit: Abbott. The FreeStyle Libre 3 reader is a standalone, small handheld device that displays real-time glucose readings. The Food and Drug Administration (FDA) has cleared a standalone reader to ...
Abbott Laboratories ABT recently made its FreeStyle Libre 3 Plus sensor available to Canadians living with diabetes. This latest generation glucose monitoring device features the world's smallest ...
This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert Senior Editor, Health and Home Anna ...